- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/74 - Complexe majeur d'histocompatibilité [MHC]
Détention brevets de la classe C07K 14/74
Brevets de cette classe: 1864
Historique des publications depuis 10 ans
|
94
|
105
|
124
|
188
|
250
|
247
|
296
|
260
|
203
|
55
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1146 |
521 |
| Cue Biopharma, Inc. | 179 |
92 |
| Regeneron Pharmaceuticals, Inc. | 4140 |
56 |
| CRISPR Therapeutics AG | 353 |
54 |
| University Health Network | 1010 |
29 |
| 10X Genomics, Inc. | 1132 |
22 |
| Board of Regents, The University of Texas System | 5689 |
18 |
| The Regents of the University of California | 19681 |
17 |
| Imcyse SA | 73 |
15 |
| Sangamo Therapeutics, Inc. | 414 |
15 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1515 |
14 |
| Oregon Health & Science University | 757 |
14 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 308 |
13 |
| Sana Biotechnology, Inc. | 149 |
13 |
| Universite de Montreal | 341 |
12 |
| Xyphos Biosciences Inc. | 34 |
12 |
| Immunocore Limited | 207 |
11 |
| UTi Limited Partnership | 442 |
11 |
| Albert Einstein College of Medicine, Inc. | 567 |
9 |
| The United States Government AS represented by The Department of Veterans Affairs | 1122 |
9 |
| Autres propriétaires | 907 |